NOGG 2024: Clinical guideline for the prevention and treatment of osteoporosis

NOGG 2024: Clinical guideline for the prevention and treatment of osteoporosis - National Osteoporosis Guideline Group (NOGG)

Scope of this guideline
a. This guideline was prepared in 2021 with the support of the societies listed to provide guidance on prevention and treatment of osteoporosis with the overarching aim of reducing fragility fracture risk.
This guideline, updated in 2024, replaces previous National Osteoporosis Guideline Group (NOGG) guidance.

b. The scope of the guideline is to review the assessment and diagnosis of osteoporosis, the therapeutic interventions available and the approaches for the prevention of fragility fractures, in postmenopausal women, and in men aged 50 years or older. This focus is chosen as fragility fractures and osteoporosis are uncommon in premenopausal women, and men younger than 50 years and therefore when these occur patients need thorough investigation for secondary causes of osteoporosis, and careful consideration of treatment options. Specialist referral is usually required.


Read full guideline